Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02390843
Title Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors (AflacST1402)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Emory University

central nervous system cancer

brain stem glioma

Advanced Solid Tumor

optic nerve glioma


Cyclophosphamide + Filgrastim + Simvastatin + Topotecan

Age Groups: adult | child
Covered Countries USA

No variant requirements are available.